PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.81%
Positive revenue growth while RUN is negative. John Neff might see a notable competitive edge here.
153.84%
Gross profit growth above 1.5x RUN's 16.26%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
29.81%
Positive EBIT growth while RUN is negative. John Neff might see a substantial edge in operational management.
33.02%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
33.08%
Net income growth under 50% of RUN's 187.43%. Michael Burry would suspect the firm is falling well behind a key competitor.
34.04%
EPS growth under 50% of RUN's 186.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
33.33%
Diluted EPS growth under 50% of RUN's 186.67%. Michael Burry would worry about an eroding competitive position or excessive dilution.
1.01%
Share change of 1.01% while RUN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.40%
Diluted share reduction more than 1.5x RUN's 2.91%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-24.60%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-3.56%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
308.66%
10Y revenue/share CAGR above 1.5x RUN's 154.21%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-40.06%
Negative 5Y CAGR while RUN stands at 154.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-47.51%
Negative 3Y CAGR while RUN stands at 154.21%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2385.62%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-48.88%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-292.11%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-15021.96%
Negative 10Y net income/share CAGR while RUN is at 187.71%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-2730.84%
Negative 5Y net income/share CAGR while RUN is 187.71%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-35.33%
Negative 3Y CAGR while RUN is 187.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
132.63%
10Y equity/share CAGR above 1.5x RUN's 33.24%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-41.36%
Negative 5Y equity/share growth while RUN is at 33.24%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
25.43%
3Y equity/share CAGR at 75-90% of RUN's 33.24%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1.74%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
1.15%
Inventory shrinking or stable vs. RUN's 32.87%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-0.46%
Negative asset growth while RUN invests at 7.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.33%
We have a declining book value while RUN shows 8.25%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
3.89%
Debt shrinking faster vs. RUN's 12.40%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
1.06%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-7.43%
We cut SG&A while RUN invests at 3.54%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.